Quick Answer
STRATA Skin Sciences, Inc. reported Cash And Cash Equivalents At Carrying Value of $7.91 million for the year ending 2025.
- STRATA Skin Sciences, Inc. showed an increase of +9.0% in Cash And Cash Equivalents At Carrying Value from 2024 to 2025.
- This data is from STRATA Skin Sciences, Inc.'s annual report (Form 10-K), filed with the SEC on March 26, 2026.
- XBRL data for this metric is available from 2008 to 2025 (24 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Over the full 24 years of available data (2008 to 2025), STRATA Skin Sciences, Inc.'s Cash And Cash Equivalents At Carrying Value has declined by 47.5%.
- Historical annual values: Fiscal year 2025: $7.91 million | Fiscal year 2024: $7.26 million | Fiscal year 2023: $6.78 million | Fiscal year 2022: $5.43 million | Fiscal year 2021: $12.59 million | Fiscal year 2020: $10.60 million | Fiscal year 2019: $8.13 million | Fiscal year 2018: $16.49 million | Fiscal year 2018: $15.89 million | Fiscal year 2018: $14.45 million | Fiscal year 2018: $3.42 million | Fiscal year 2017: $4.07 million | Fiscal year 2017: $3.13 million | Fiscal year 2017: $3.94 million | Fiscal year 2017: $3.76 million | Fiscal year 2016: $3.93 million | Fiscal year 2015: $3.30 million | Fiscal year 2014: $11.43 million | Fiscal year 2013: $3.78 million | Fiscal year 2012: $7.86 million | Fiscal year 2011: $28.00 million | Fiscal year 2010: $30.52 million | Fiscal year 2009: $29.67 million | Fiscal year 2008: $15.07 million.
- Data sourced from SEC EDGAR public filings as of June 23, 2026.
Last verified: